Literature DB >> 29184473

Neoadjuvant Treatment Strategies: Advanced Radiation Alternatives.

Bruce D Minsky1.   

Abstract

Long-course chemoradiation therapy (CRT) has been the standard approach for locally advanced rectal tumors. Neoadjuvant CRT is associated to improved local disease control, with less toxicity when compared with adjuvant CRT, as well as the chance for pathologic complete response. The CRT regimens have improved over the past years. This article will examine selected controversies, including novel chemoradiation regimens, duration of radiation (short vs. long course), and radiation techniques such as intensity-modulated radiation therapy (IMRT).

Entities:  

Keywords:  IMRT; chemoradiation therapy; long course; rectal cancer; short course

Year:  2017        PMID: 29184473      PMCID: PMC5703672          DOI: 10.1055/s-0037-1606115

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  43 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.

Authors:  Lin Wang; Zi-Yu Li; Zhong-Wu Li; Yong-Heng Li; Ying-Shi Sun; Jia-Fu Ji; Jin Gu; Yong Cai
Journal:  Dis Colon Rectum       Date:  2015-02       Impact factor: 4.585

3.  Preoperative hyper-fractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trial.

Authors:  Philippe A Coucke; Markus Notter; Bernhard Stamm; Maurice Matter; Fabrizio Fasolini; Rolph Schlumpf; Oscar Matzinger; Hanifa Bouzourene
Journal:  Radiother Oncol       Date:  2006-03-27       Impact factor: 6.280

4.  Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer--a two stage phase II clinical trial.

Authors:  Gudrun Resch; Alexander De Vries; Dietmar Öfner; Wolfgang Eisterer; Hans Rabl; Michael Jagoditsch; Michael Gnant; Josef Thaler
Journal:  Radiother Oncol       Date:  2011-07-07       Impact factor: 6.280

5.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.

Authors:  J van der Zee; D González González; G C van Rhoon; J D van Dijk; W L van Putten; A A Hart
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

6.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

7.  A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancer.

Authors:  Jeroen Buijsen; Jørgen van den Bogaard; Barry Jutten; Eric Belgers; Meindert Sosef; Jeroen W A Leijtens; Geerard L Beets; Rob L H Jansen; Robert G Riedl; Ruud Clarijs; Guido Lammering; Philippe Lambin
Journal:  Radiother Oncol       Date:  2015-08-04       Impact factor: 6.280

8.  Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

Authors:  Jean-Pierre Gérard; David Azria; Sophie Gourgou-Bourgade; Isabelle Martel-Lafay; Christophe Hennequin; Pierre-Luc Etienne; Véronique Vendrely; Eric François; Guy de La Roche; Olivier Bouché; Xavier Mirabel; Bernard Denis; Laurent Mineur; Jean-François Berdah; Marc-André Mahé; Yves Bécouarn; Olivier Dupuis; Gérard Lledo; Jean-François Seitz; Laurent Bedenne; Béata Juzyna; Thierry Conroy
Journal:  J Clin Oncol       Date:  2012-10-29       Impact factor: 44.544

9.  Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01).

Authors:  Seung-Gu Yeo; Jae Hwan Oh; Dae Yong Kim; Ji Yeon Baek; Sun Young Kim; Ji Won Park; Min Ju Kim; Hee Jin Chang; Tae Hyun Kim; Jong Hoon Lee; Hong Seok Jang; Jun-Gi Kim; Myung Ah Lee; Taek-Keun Nam
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-12-19       Impact factor: 7.038

10.  Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect.

Authors:  Jorine H M Juffermans; Patrick E J Hanssens; Wim L J van Putten; Gerard C van Rhoon; Jacoba van Der Zee
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.